Discovery of Natural Product Compounds as Dengue Virus NS5 Methyltransferase Inhibitor Candidate through in Silico Method

Abstract:

Dengue is a global health problem which predominantly affected the tropical and subtropical region of Asia, Africa, and America. However, there are no available antiviral agents to treat dengue virus (DENV) infection. This study was conducted to utilize natural product compounds as an inhibitor of NS5 Methyltransferase, a viral protein which plays an essential role in the synthesis of DENV RNA. The natural product compounds were collected from the Universal Natural Product Database (UNPD), totaling 229,000 compounds. The in silico screening of the natural product compounds was performed by molecular docking simulation method, which simulates the interaction of the compounds on the active site of the NS5 methyltransferase. From the molecular docking simulation, about 51 compounds showed better affinity and interaction compared to the standard compound, S-Adenosyl-L-Homocysteine (SAH). Then, a series of pharmacological tests were performed to find the best drug candidates by employing DataWarrior and SwissADME software. Finally, three natural product compounds, namely UNPD98966, UNPD183023, and UNDP104952, were regarded as the best inhibitor against NS5 methyltransferase based on its molecular affinity and interaction. These compounds also showed potential as drug candidates due to their desirable pharmacological properties.

• Periodical: Key Engineering Materials (Volume 840)
• Pages: 270-276
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.840.270
• Online since: April 2020
• Authors: Anjas Randy Bagastama, Ahmad Husein Alkaff, Usman Sumo Friend Tambunan*
• Keywords: Dengue Virus, Molecular Docking, Natural Product, NS5 Methyltransferase, Virtual Screening

References

[1] World Health Organization and Ministry of Health of the Republic of Indonesia, Prevention and control of dengue fever and dengue fever, World Health Organization and Ministry of Health of the Republic of Indonesia, Jakarta, (2014).

DOI: 10.25133/jpssv27n1.003

[2] R.J. Kuhn, W. Zhang, M.G. Rossmann, S.V. Pletney, J. Corver, E. Lenches, C.T. Jones, S. Mukhopadhyay, P.R. Chipman, E.G. Strauss, T.S. Baker, J.H. Strauss, Structure of dengue virus: implications for flavivirus organization, maturation, and fusion, Cell. 108 (2002) 717-725.

DOI: 10.1016/s0092-8674(02)00660-8

[3] U.S.F. Tambunan, A.H. Alkaff, Identification of natural products as an inhibitor of β-OG pocket binder of dengue virus envelope protein using fragment-based drug design and molecular docking approach, AIP Conference Proceedings 2023 (2018) 020059.

DOI: 10.1063/1.5064056

[4] M.A.F. Nasution, E.P. Toepak, A.H. Alkaff, U.S.F. Tambunan, Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus nucleocapsid (ebov np): a computational approach to discover new drug for combating Ebola, BMC Bioinformatics 19 (2018) 137-176.

DOI: 10.1186/s12859-018-2387-8

[5] U. Raj, P.K. Varadwaj, Flavonoids as multi-target inhibitors for proteins associated with ebola virus: in silico discovery using virtual screening and molecular docking studies, Interdiscip. Sci. 8 (2016) 132–141.

DOI: 10.1007/s12539-015-0109-8

[6] M.W. El-Saadi, T. Williams-Hart, B.A. Salvatore, E. Mahdavian, Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent, In Silico Pharmacol. 3 (2015) 6.

DOI: 10.1186/s40203-015-0010-5

[7] S.J. Enoch, M. Hewitt, M.T.D. Cronin, S. Azam, J.C. Madden, Classification of chemicals according to mechanism of aquatic toxicity: an evaluation of the implementation of the Verhaar scheme in Toxtree, Chemosphere. 73 (2008) 243-248.

DOI: 10.1016/j.chemosphere.2008.06.052

[8] D.B. Kitchen, H. Decornez, J.R. Furr, J. Bajorath, Docking and scoring in virtual screening for drug discovery: Methods and applications, Nat. Rev. Drug. Discov. 3 (2004) 935–949.

DOI: 10.1038/nrd1549

[9] D. Hecht, and G. B. Fogel, Computational intelligence methods for docking scores, Curr. Comput-aid Drug 5 (2009) 56–68.

[10] R. Begini, C. Bossa, N. Jeliazkova, T. Netzava, A. Worth, The Benigni/Bossa rulebase for mutagenicity and carcinogenicity - a module of Toxtree, JRC Scientific and Technical Reports (2008) 1-63.

[11] A. Daina, O. Michielin, V. Zoete, SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Sci. Rep. 7 (2017) 42717.

DOI: 10.1038/srep42717

[12] S.F. Zhou, Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4, Curr. Drug. Metab. 9 (2008) 310-322.

DOI: 10.2174/138920008784220664